日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule

荷兰皮肤T细胞淋巴瘤的全皮肤电子束治疗:治疗结果的回顾性分析以及高剂量或低剂量方案的选择

Smits, K; Quint, K D; Vermeer, M H; Daniëls, L A; Willemze, R; Jansen, P M; Jansen, W P A; Neelis, K J

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study

早期蕈样肉芽肿的治疗:前瞻性皮肤淋巴瘤国际预后指数(PROCLIPI)研究的结果

Quaglino, P; Prince, H M; Cowan, R; Vermeer, M; Papadavid, E; Bagot, M; Servitjie, O; Berti, E; Guenova, E; Stadler, R; Querfeld, C; Busschots, A M; Hodak, E; Patsatsi, A; Sanches, J; Maule, M; Yoo, J; Kevin, M; Fava, P; Ribero, S; Zocchi, L; Rubatto, M; Fierro, M T; Wehkamp, U; Marshalko, M; Mitteldorf, C; Akilov, O; Ortiz-Romero, P; Estrach, T; Vakeva, L; Enz, P A; Wobser, M; Bayne, M; Jonak, C; Rubeta, M; Forbes, A; Bates, A; Battistella, M; Amel-Kashipaz, R; Vydianath, B; Combalia, A; Georgiou, E; Hauben, E; Hong, E K; Jost, M; Knobler, R; Amitay-Laish, I; Miyashiro, D; Cury-Martins, J; Martinez, X; Muniesa, C; Prag-Naveh, H; Stratigos, A; Nikolaou, V; Quint, K; Ram-Wolff, C; Rieger, K; Stranzenbach, R; Szepesi, Á; Alberti-Violetti, S; Felicity, E; Cerroni, L; Kempf, W; Whittaker, S; Willemze, R; Kim, Y; Scarisbrick, J J

Incidence of mycosis fungoides and Sézary syndrome in the Netherlands between 2000 and 2020

2000年至2020年间荷兰蕈样肉芽肿和塞扎里综合征的发病率

Ottevanger, R; de Bruin, D T; Willemze, R; Jansen, P M; Bekkenk, M W; de Haas, E R M; Horvath, B; van Rossum, M M; Sanders, C J G; Veraart, J C J M; Vermeer, M H; Quint, K D

Quality of life in patients with Mycosis Fungoides and Sézary Syndrome: a systematic review of the literature

蕈样肉芽肿和塞扎里综合征患者的生活质量:文献系统综述

Ottevanger, R; van Beugen, S; Evers, A W M; Willemze, R; Vermeer, M H; Quint, K D

Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants.

皮肤T细胞淋巴瘤变异株中IL31的血清和皮肤转录表达水平极低

van Santen S, Out J J, Zoutman W H, Quint K D, Willemze R, Vermeer M H, Tensen C P

Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis

504例淋巴瘤样丘疹病患者相关恶性肿瘤的发生率和预后

Melchers, R C; Willemze, R; Bekkenk, M W; de Haas, E R M; Horvath, B; van Rossum, M M; Sanders, C J G; Veraart, J C J M; Putter, H; Jansen, P M; Vermeer, M H; Quint, K D

KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia

移植物抗宿主方向的KIR配体不相容性可改善急性白血病脐带血移植后的预后。

Willemze, R; Rodrigues, C A; Labopin, M; Sanz, G; Michel, G; Socié, G; Rio, B; Sirvent, A; Renaud, M; Madero, L; Mohty, M; Ferra, C; Garnier, F; Loiseau, P; Garcia, J; Lecchi, L; Kögler, G; Beguin, Y; Navarrete, C; Devos, T; Ionescu, I; Boudjedir, K; Herr, A-L; Gluckman, E; Rocha, V

Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex

由单个T细胞受体复合物介导的同种异体反应性T淋巴细胞的双重HLA I类和II类限制性识别

Heemskerk, M H; de Paus, R A; Lurvink, E G; Koning, F; Mulder, A; Willemze, R; van Rood, J J; Falkenburg, J H

Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype

杀伤细胞抑制性受体的表达仅限于真正的NK细胞淋巴瘤和具有细胞毒性表型的肠病型T细胞淋巴瘤的一个亚群

Dukers, D F; Vermeer, M H; Jaspars, L H; Sander, C A; Flaig, M J; Vos, W; Willemze, R; Meijer, C J

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

结外间变性大细胞淋巴瘤中ALK表达提示系统性疾病(原发性淋巴结受累)预后良好,且ALK表达发生于疾病播散之前。

ten Berge, R L; Oudejans, J J; Ossenkoppele, G J; Pulford, K; Willemze, R; Falini, B; Chott, A; Meijer, C J